Type 2 diabetes is one of the most common, costly, and disabling diseases in the world. Approximately one million patients in Michigan have type 2 diabetes and rates are up to 2x higher for Michiganders who are Black, Latino, or have a disability. At the same time, the implementation of guideline concordant diabetes care lags behind due to challenges with coverage, lack of resources, cost of medications, and lack of support and education. Primary care practices continue to combat staffing issues, lack of resources, and increasing administrative demands. Meanwhile coordination of care for diabetes is confounded by an increasingly-complex healthcare system.
The Michigan Collaborative for Type 2 Diabetes (MCT2D) was established in 2021 to accelerate a new way forward, through collaboration, innovation, and investment in quality, evidence based care for type 2 diabetes. MCT2D strives to remove barriers to guideline concordant care, support participating practices, and keep patients central to quality improvement work.

Mission

MCT2D strives to prevent type 2 diabetes and its complications by fostering a collaborative community of clinicians and patients to accelerate the equitable implementation of evidence-based diabetes care for all patients in Michigan.

Vision

A world where Type 2 Diabetes is no longer a progressive disease.

Quality Initiatives

Together, we work to accelerate the implementation of quality diabetes care, including three guiding initiatives

MORE ON QUALITY INITIATIVES

How MCT2D Supports Members

Meet the Program Directors

OUR TEAM

Read our Latest Annual Report

2023 Annual Report2022 Annual Report

PRESENTATIONS AND PUBLICATIONS

Go to Publications page

NEWSLETTERS

News from the MCT2D Team


four clinicians standing smiling
Top Takeaways: New Primary Care Practices Respond to MCT2D Patient Needs Assessment Survey

Last updated: Thursday, March 13, 2025

Between September 15 and December 31, 2024, MCT2D invited newly joined primary care practices to collect patient feedback through a patient needs assessment survey. Each practice was asked to have at least 10 patients complete the assessment during this period. The purpose of the survey was to gather a collaborative-wide assessment of:
New Resource: CGM Ordering Quick Reference Guide

Last updated: Thursday, February 27, 2025

To get groceries, you go to a grocery store. To get prescription medications, you go to a pharmacy. Knowing who supplies these items and where to obtain them is relatively simple. However, the supply and pick-up pipeline for continuous glucose monitoring (CGM) devices can vary based on one's health insurance. This information is unclear even to physicians prescribing CGM, with many prescribers stuck with the question, "Where do I send the CGM order: Pharmacy or DME?" and left to guess and hope for the best.
We've created a one-page quick reference guide, CGM ORDERING: PHARMACY or DME, to support more efficient and effective CGM prescribing. The guide outlines CGM ordering by major Michigan insurance plans/payors, based on each plan's line of coverage. The goal of creating this tool is to save clinical time and get patients CGMs more quickly and efficiently.
Development of the tool was led by Heidi Diez, PharmD, MCT2D Program Co-Director. It is available in the MCT2D Resource Library.
MCT2D Annual Report 2024

Last updated: Friday, January 31, 2025

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org